Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR SYNERGY (OASIS 9) – Colchicine in STEMI after PCI
2017-000487-15Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Feb 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Colchicine with Placebo (2 arms). Primary endpoint: Primary composite endpoint (colchicine vs placebo). Started Feb 2018; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2017-000487-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000487-15.